

[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI
[ Fri, Jun 01st 2018
] - WOPRAI

[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $25 on, May 31st, 2018
Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $24 to $25 on, May 31st, 2018.
Liav has made no other calls on TEVA in the last 4 months.
There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 3 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $20 on, Thursday, May 24th, 2018
- David Risinger of "Morgan Stanley" Maintained at Hold on, Monday, May 7th, 2018
- Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Decreased Target to $18 on, Friday, February 9th, 2018
These are the ratings of the 4 analyists that currently disagree with Liav
- Vamil Divan of "Credit Suisse" Maintained at Buy with Increased Target to $23 on, Monday, February 12th, 2018
- Jason Gerberry of "B of A Securities" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
- Ami Fadia of "Leerink Swann" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
- David Amsellem of "Piper Sandler" Downgraded from Hold to Sell on, Friday, February 9th, 2018